Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Sep 15, 2024; 16(9): 3832-3838
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.3832
Published online Sep 15, 2024. doi: 10.4251/wjgo.v16.i9.3832
Clinical significance of peripheral blood UL16 and DR-70 for the early diagnosis and prognostic evaluation of colorectal cancer
Zhi-Ping Zong, Department of Blood Transfusion, Affiliated Hospital of Jiangnan University, Wuxi 214000, Jiangsu Province, China
Chen Wu, Clinical Laboratory, Jiangsu Province Official Hospital, Nanjing 210003, Jiangsu Province, China
Author contributions: Zong ZP and Wu C designed the study; Zong ZP and Wu C analyzed the data; Zong ZP performed data collection and wrote the manuscript; all authors have read and approved the final manuscript.
Institutional review board statement: The study was reviewed and approved by the Institutional Review Board of the Affiliated Hospital of Jiangnan University.
Informed consent statement: All study participants or their legal guardians provided written informed consent prior to their participation in this study.
Conflict-of-interest statement: The authors declare no conflicts of interest.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Chen Wu, BMed, Technician, Clinical Laboratory, Jiangsu Province Official Hospital, No. 65 Jiangsu Road, Gulou District, Nanjing 210003, Jiangsu Province, China. 15251848843@163.com
Received: July 15, 2024
Revised: August 13, 2024
Accepted: August 14, 2024
Published online: September 15, 2024
Processing time: 55 Days and 15.4 Hours
Revised: August 13, 2024
Accepted: August 14, 2024
Published online: September 15, 2024
Processing time: 55 Days and 15.4 Hours
Core Tip
Core Tip: The combination of Peripheral blood UL16-binding protein 2 (ULBP2) and human fibrinogen degradation products (DR-70) can obviously improve the diagnostic value of early colorectal cancer (CRC), which is very important for the early diagnosis and treatment of CRC. This study confirmed the diagnostic value of serum ULBP2 and DR-70 levels in early CRC patients by observing their serum ULBP2 and DR-70 levels.